ST6GALNAC5 (C-term), 110-138 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-ST6GALNAC5 (C-term), 110-138 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | ST6GALNAC5 (C-term), 110-138 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.34 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This ST6GALNAC5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 110-138 amino acids from the C-terminal region of human ST6GALNAC5. ST6GALNAC5 belongs to a family of sialyltransferases thatmodify proteins and ceramides on the cell surface to altercell-cell or cell-extracellular matrix interactions (Tsuchida etal., 2003 [PubMed 12668675]). |
| Immunogen | n/a |
| Other Names | [Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5; 2499-; GD1 alpha synthase; GalNAc alpha-2,6-sialyltransferase V; ST6GalNAc V; ST6GalNAcV; Sialyltransferase 7E; SIAT7-E; ST6GALNAC5; SIAT7E] |
| Gene, Accession # | [ST6GALNAC5], Gene ID: 81849, NCBI: NP_112227.1, UniProt: Q9BVH7 |
| Catalog # | MBS9209641 |
| Price | $165, $370 |
| Order / More Info | ST6GALNAC5 (C-term), 110-138 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Rose, J. Phd, et al. Mol. Med. (2010) In press : Harduin-Lepers, A., et al. Glycobiology 15(8):805-817(2005) Tsuchida, A., et al. J. Biol. Chem. 278(25):22787-22794(2003) Ikehara, Y., et al. FEBS Lett. 463 (1-2), 92-96 (1999) : Okajima, T., et al. J. Biol. Chem. 274(43):30557-30562(1999) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies